People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The company says its new drug in pill form is as safe and effective as Ozempic and other popular injectables for weight loss ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

There's new research linking senolytics to helping slow down Alzheimer's progression. Here's how and what experts have to say ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

“Best known as a trusted nausea remedy, ginger tea has a spicy and full-bodied flavour,” they said. “It contains the ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity ...